SecBot SecBot

BEAT

HeartBeam, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001779372 Healthcare & Medical Devices
$0.3924 −0.00 (−0.15%)
Oct 26 4:00 PM ET · prev $0.3930
Market cap
$22.4M
Nano cap
Consensus
Buy
78% Buy or better · 9 analysts
Median target
$3.50
+792% · range $2.00–5.00
Next earnings
Nov 5
in 10 days · EPS est. −$0.09
1 year
−75.6%
from $1.61 · Oct 27
30 days
+5.2%
from $0.3730
52-week range
$0.3600–3.44
−89% from high · low Sep 25
Avg volume 20D
22.26M
Oct 5 spike 404.24M
Short interest
2.49M
≈4.4% of shares · +17.4%
Days to cover
6.2
at average volume
Insider net
+$951.0K
8 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BEARISH 2 reports · 90 days
Balance 2 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 2/2 ·Next Earnings date, Nov 5, 2026
Strongest BEARISH HeartBeam, Inc. filed an 8-K announcing entry into an at-the-market (ATM) equity offering sales agreement…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    8 insiders bought $951.0K at an average $0.8000. No open-market sales. Price is 51% below their cost.

  • InstitutionsBULLISH

    Q2 2026: 6 added (0 new), 0 trimmed or exited.

  • AnalystsBULLISH

    7 of 9 rate it Buy or better. Every target is above the price.

  • EstimatesFLAT

    Current-quarter EPS estimate −$0.090 → −$0.090 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersBUILDING

    Short interest +17.4% to 2.49M shares. 6.2 days to cover, ≈4.4% of shares.

  • TrendRANGE

    11% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCADD2,137,512$1.6M
GEODE CAPITAL MANAGEMENT, LLCADD479,386$359.6K
VANGUARD FIDUCIARY TRUST COADD274,818$206.1K
RAYMOND JAMES FINANCIAL INCADD134,434$100.8K
NORTHERN TRUST CORPADD101,129$75.8K
CIBC Bancorp USA Inc.ADD20,631$15.5K
UBS Group AGTRIM335,189$408.9K
O'SHAUGHNESSY ASSET MANAGEMENT, LLCADD208,191$254.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 78% rate it Buy or better
Strong Buy2Buy5Hold2Sell0Strong Sell0
12-month targets · 2 analysts

Price is below the lowest target. Median implies +792%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Sep 22, 2026HC Wainwright & Co.
DOWNGRADE
DOWNGRADENeutral
Jul 14, 2026Maxim Group
INITIATE
INITIATEBuy
May 22, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
May 15, 2026Benchmark
MAINTAIN
MAINTAINSpeculative Buy

Insider ledger

Form 4
$951.0K
bought · 8 insiders
$0
sold · 0 insiders
−51.0%
vs their $0.8000 cost
DateInsiderTypeValue
Oct 2, 2026
Elfrink Willem
Director
AWARD93,750 sh
Oct 2, 2026
Ferrari Richard
Director
AWARD125,000 sh
Oct 2, 2026
Ferrari Richard
Director
AWARD125,000 sh
Oct 2, 2026
Ferrari Richard
Director
AWARD90,625 sh
Oct 2, 2026
Nelson Kenneth Warwick III
Director
AWARD93,750 sh
Oct 2, 2026
de Urioste George
Director
AWARD93,750 sh
Oct 2, 2026
de Urioste George
Director
AWARD93,750 sh
Oct 2, 2026
Ortigas-Wedekind Marga
Director
AWARD93,750 sh

Earnings setup

Estimates
Nov 5
reports in 10 days
−$0.09
EPS estimate, this quarter
0%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.09-$0.10–-$0.08+3.6%$80.0K
Next Q-$0.09-$0.10–-$0.08+3.7%$208.3K
Current FY-$0.38-$0.41–-$0.37+3.4%$288.3K
Next FY-$0.29-$0.34–-$0.24+7.5%$3.7M

Short side

FINRA· Sep 30, 2026
2,493,900
shares short
+17.4%
vs prior settlement
6.2
days to cover
≈4.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 2, 2026 Insider
Elfrink Willem was granted 93,750 shares
Director
Oct 2, 2026 Insider
Ferrari Richard was granted 125,000 shares
Director
Oct 2, 2026 Insider
Ferrari Richard was granted 125,000 shares
Director
Aug 14, 2026 SEC
HeartBeam, Inc. filed an 8-K announcing entry into an at-the-market (ATM) equity offering sales agreement with Titan…
8-K, 424B5 — Impact 6/10
Aug 14, 2026 SEC
HeartBeam filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $25 million in common stock…
424B5 — Impact 6/10
Aug 14, 2026 Short interest report
Short Interest: BEAT up 32% to 2.4M shares
Settlement 2026-08-14 | Days to cover: 4.01 | ≈4.31% of shares outstanding (est.)
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — ADD
2,137,512 shares ($1.6M)
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — ADD
479,386 shares ($359.6K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
BEAT Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Aug 14, 2026
Short interest
Short Interest: BEAT up 32% to 2.4M shares
Settlement 2026-08-14 | Days to cover: 4.01 | ≈4.31% of shares outstanding (est.)
Aug 13, 2026
Earnings date
BEAT Q2 2026 Earnings Scheduled — 2026-08-13
Aug 6, 2026
Earnings date
BEAT Q2 2026 Earnings Scheduled — 2026-08-06
Jul 31, 2026
Short interest
Short Interest: BEAT down 28% to 1.8M shares
Settlement 2026-07-31 | Days to cover: 4.61 | ≈3.31% of shares outstanding (est.)
Jul 15, 2026
Short interest
Short Interest: BEAT up 42% to 2.5M shares
Settlement 2026-07-15 | Days to cover: 1.51 | ≈4.58% of shares outstanding (est.)

SecBot reports

7 filings · 0 bullish · 3 bearish · 2 mixed · 2 neutral
All BEAT filing & press-release reports (7)